Gabapentin for HIV-associated Neuropathic Pain: A Review of the Clinical Effectiveness


( Last Updated : January 22, 2016)
Project Line:
Health Technology Review
Project Sub Line:
Summary with Critical Appraisal
Project Number:
RC0750-000

Details


Question


  1. What is the clinical effectiveness of gabapentin for the treatment of HIV-associated neuropathic pain?


Key Message

There is limited evidence for the use of gabapentin for the treatment of HIV-associated neuropathy. One relevant RCT, included in a systematic review, and one non-randomized study were identified. The studies suggest that gabapentin may improve pain and related sleep disturbances caused by HIV-associated sensory neuropathy; however, due to the limitations of the evidence, the effectiveness of gabapentin for patients with HIV-associated neuropathy is inconclusive.